Status:

RECRUITING

Benefits and Risks of Artificial Light Exposure: Characterisation of Effects on Alertness, Sleep, Cognitive Performance, Mood and Biological Rhythms

Lead Sponsor:

University Hospital, Strasbourg, France

Conditions:

Human Sleep and Chronobiology

Eligibility:

All Genders

18-40 years

Phase:

NA

Brief Summary

The purpose of this project is to study the influence of light on sleep, wakefulness, EEG activity and cognitive performances.

Eligibility Criteria

Inclusion

  • Male or female
  • Aged 18 to 40 years
  • With a hint of Bodymass index (BMI) between 17 and 30 kg.m - 2
  • healthy subject determined by a clinical examination, a psychological interview, a blood test, a urine analysis
  • Subject with a score\<6 questionnaire PSQI ("Sleep Questionnaire Pittsburgh")
  • Subject agreeing to maintain a regular sleep/wake rhythm during the study
  • Subject agreeing to refrain from caffeine, nicotine, alcohol, psychotropic drugs, cannabis or other drugs, during the study
  • Signed informed consent
  • Subjectaffiliated to a social protection scheme

Exclusion

  • somatic diseases: cardiovascular, respiratory, gastrointestinal, hematopoietic, Visual
  • immune system diseases
  • kidneys and urinary tract diseases
  • endocrine and metabolic diseases
  • neurological diseases
  • infectious diseases
  • thrombocytopenia or other malfunction of blood platelets
  • Subject with risk of thrombosis, including subject with a history of phlebitis, smoker under oral contraceptive...
  • Subject with an addiction to caffeine, nicotine, alcohol, psychotropic drugs, cannabis, or any other drug
  • Subject treatment contraindicated or inadvisable in combination with heparin
  • blood donation in the previous 3 months before the inclusion
  • Participation in other clinical trials
  • Work by shifts in the year preceding the inclusion
  • Trans-meridian travel (\> 2 time zones) in the month previous the inclusion
  • Impossibility to give enlightened information (subject in an emergency situation, understanding difficulties,...)
  • Subject under safeguard of justice
  • Subject under tutorship or curatorship
  • Pregnancy (women of childbearing age)
  • Breastfeeding
  • Diet incompatible with the study's snack choices

Key Trial Info

Start Date :

December 2 2021

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

May 1 2026

Estimated Enrollment :

96 Patients enrolled

Trial Details

Trial ID

NCT05232383

Start Date

December 2 2021

End Date

May 1 2026

Last Update

August 8 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Hôpitaux Universitaires de Strasbourg

Strasbourg, France, 67091